Anaes Vivas · Anaesthetic adjuncts
Data viva — dobutamine and dopamine among the inotropes
A data viva placing dobutamine against dopamine and adrenaline. The discriminating data points: dobutamine is a synthetic predominantly beta-1 inotrope with weak beta-2 and alpha-1 (beta-2 offsets alpha-1, so vasodilating at clinical dose — taught pharmacology), no indirect component, less tachyarrhythmia, lowers PVR, and is the standard stress-testing agent for dobutamine stress echocardiography (prognostic cohort-exact, Dippenaar 2026). Dopamine is the natural noradrenaline precursor with direct plus indirect action and dose-dependent selectivity (taught tiers; the porcine study owns no dosing claim, Routkevitch 2026), is more arrhythmogenic (indirect noradrenaline release), raises PVR, and has the trial-exact disproven renal-dose concept (328 patients, Bellomo 2000); it is one of the compared options in neonatal fluid-refractory septic shock with no superiority (4-RCT null, Yahya 2026). Adrenaline is the broadest agent (alpha-1, alpha-2, beta-1, beta-2) and the most arrhythmogenic (taught ranking). All three share a half-life of about 2 minutes, COMT metabolism, tachyphylaxis after 48 to 72 hours (taught pharmacology), and extravasation necrosis reversed by phentolamine (cohort-exact, Shyu 2025). Delirium null in older adults (Dong 2026) frames the selection logic.
On this page
Study tools
Target exams
Stimulus
A table summarises three inotropic catecholamines used in anaesthesia and intensive care against six properties:
| Agent | Dominant receptor profile | Mechanism of beta-1 stimulation | Dose-dependent selectivity | Vascular effect at clinical dose | Arrhythmogenic liability | Effect on PVR |
|---|---|---|---|---|---|---|
| Dobutamine | Predominantly beta-1; weak beta-2 and alpha-1 | Direct only | No (beta-1 dominant throughout) | Vasodilating (beta-2 offsets alpha-1) | Lowest of the three | Lowers |
| Dopamine | D1, beta-1, alpha-1 (dose-dependent) | Direct plus indirect (noradrenaline release) | Yes (D1 to beta-1 to alpha-1) | Variable; vasoconstricting at high dose | Higher than dobutamine | Raises |
| Adrenaline | Alpha-1, alpha-2, beta-1, beta-2 | Direct only | Yes (low beta-2 to high alpha-1) | Variable; vasoconstricting at high dose | Highest | Raises |
Interpret the table and justify the clinical selection for each of the following scenarios: cardiogenic shock with a high pulmonary capillary wedge pressure, neonatal fluid-refractory septic shock, pharmacological stress echocardiography in a patient unable to exercise, and an older adult at risk of delirium with intraoperative hypotension.[1][2]
References6ShowHide
- [1]Dippenaar AP, et al. Prognostic value of dobutamine stress echocardiography. Cardiovasc J Afr, 2026.PMID 42345272
- [2]Routkevitch D, et al. Response of Spinal Cord Blood Flow to Hypotensive and Adrenergic Challenges: Dopamine. Neurosurgery, 2026.PMID 42340304
- [3]Dong T, et al. Vasopressor Selection and Postoperative Delirium in Older Adults. Semin Cardiothorac Vasc Anesth, 2026.PMID 42359892
- [4]Yahya R, et al. First-line vasopressor therapy in neonates with fluid-refractory septic shock. Am J Emerg Med, 2026.PMID 42361705
- [5]Bellomo R, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet, 2000.PMID 11191541
- [6]Shyu D, et al. Overview of Peripheral Vasopressor Use in an Academic Health System. Ann Am Thorac Soc, 2025.PMID 40126143